Dr. Megan Rutter (Nottingham, UK) returns to the podcast to provide an update on her research into COVID-19 infection, admission and death amongst people with rare autoimmune rheumatic disease (RAIRD).
Dr. Chris Wincup asks Prof David Isenberg (UCL, UK) about his work to compare IgG vs IgG + IgM anti-double stranded DNA measurement in patients with SLE. They discuss the history of this work, the importance of treating the patient
Dr. Chris Wincup asks Prof David Isenberg (UCL, UK) about his work to compare IgG vs IgG + IgM anti-double stranded DNA measurement in patients with SLE. They discuss the history of this work, the importance of treating the patient
Dr. Puja Mehta talks to Dr. Grant Schulert (Cincinnati Children’s Hospital, USA) and Dr Christoph Kessel (Universitätsklinikum Münster, Germany) about identifying biomarkers for cytokine storm syndromes in children.
Dr. Puja Mehta talks to Dr. Grant Schulert (Cincinnati Children’s Hospital, USA) and Dr Christoph Kessel (Universitätsklinikum Münster, Germany) about identifying biomarkers for cytokine storm syndromes in children.
Caroline Groves asks Prof. Frances Williams (Guy’s and St. Thomas’ NHS Foundation Trust and King’s College London, UK) about the association between chronic widespread pain and the gut microbiome.
Prithvi Gaur and Dr. Iona Thorne (Chelsea and Westminster NHS Hospitals Foundation Trust) discuss the 2019 MHRA drug safety update, which includes pregnancy prevention guidance for women treated with potentially teratogenic drugs.
Prithvi Gaur and Dr. Iona Thorne (Chelsea and Westminster NHS Hospitals Foundation Trust) discuss the 2019 MHRA drug safety update, which includes pregnancy prevention guidance for women treated with potentially teratogenic drugs.
Dr. Sean Gill and Dr. Chetan Mukhtyar (Norfolk and Norwich University Hospital, UK) discuss the efficacy of tocilizumab for GCA, based on a 12-month extension of Stone et al.’s landmark clinical trial. Dr Mukhtyar provides an overview of the trial
Dr. Sean Gill and Dr. Chetan Mukhtyar (Norfolk and Norwich University Hospital, UK) discuss the efficacy of tocilizumab for GCA, based on a 12-month extension of Stone et al.’s landmark clinical trial. Dr Mukhtyar provides an overview of the trial
14 min
About The Rheumatology Podcast
From the publisher's feed
Rheumatology provides free podcast interviews with experts in the field on key topics.